Target intelligence / Profile preview

Respiratory syncytial virus large (L) protein (RSV L protein)

Target
RSV L protein
Molecular classification
Enzyme
01

Overview

The Respiratory syncytial virus large (L) protein, also known as the RSV RNA-directed RNA polymerase or RdRp, is a multifunctional ~250 kDa enzyme that serves as the catalytic core of the viral polymerase complex, responsible for RNA genome replication and transcription into viral mRNAs. It harbors three conserved enzymatic domains: the RNA-dependent RNA polymerase (RdRp) domain for nucleotide polymerization, the polyribonucleotidyl transferase (PRNTase or capping) domain for 5' cap addition, and the methyltransferase (MTase) domain for cap methylation, along with facilitating polyadenylation of subgenomic mRNAs. The L protein forms a complex with the tetrameric phosphoprotein (P), which acts as a cofactor, recruiting other viral proteins like nucleoprotein (N) and M2-1 processivity factor to the helical nucleocapsid template for coordinated RNA synthesis. Cryo-EM structures reveal L in elongation-compatible states bound to P and RNA promoters, with P adopting a tentacular arrangement to grip L and regulate activity. In RSV disease, a major cause of respiratory infection especially in infants, the polymerase is a key therapeutic target, with small-molecule inhibitors like ALS-8112 and MRK-1 blocking replication by mimicking nucleosides or altering the active site. Structures rationalize resistance mechanisms and support antiviral design against this non-segmented negative-sense RNA virus.

Other names
RNA-directed RNA polymeraseRdRpRNA-dependent RNA polymerasereplicasetranscriptase
02

Mechanism of action

Nucleoside analog incorporation leading to chain termination, allosteric inhibition of polymerase active site

03

Biological functions

RNA replicationRNA transcriptionnucleotide polymerizationcap additioncap methylationmRNA polyadenylation
04

Disease associations

Infection
05

Safety considerations

Inhibitor escape mutants (e.g., A789V, L795I, I796V substitutions)mutations in live-attenuated vaccine candidates
06

Interacting drugs

ALS-8112 (also known as ALS-8112-TP)

1 more in the full profile.

Beyond the preview

Go deeper on Respiratory syncytial virus large (L) protein (RSV L protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory syncytial virus large (L) protein (RSV L protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call